Get startedLog in
    Picture of Exact Therapeutics AS logo

    EXTX — Exact Therapeutics AS News Story

    0.000.00%
    no flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Exact Therapeutics Gets Approval To Reopen Activate Clinical Trial

    Picture of Exact Therapeutics AS logoExact Therapeutics AS
    02/02/2023 12:20
    Feb 2 (Reuters) - Exact Therapeutics AS  EXTX.OL :
    * EXACT THERAPEUTICS RECEIVES REGULATORY APPROVAL TO REOPEN
THE
ACTIVATE CLINICAL TRIAL
    * UK MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY
(MHRA)
HAS APPROVED REOPENING OF CLINICAL PHASE I ACTIVATE TRIAL

Source text for Eikon:  ID:nObi4BnL3a 
Further company coverage:  EXTX.OL 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Exact Therapeutics AS

    See all news